Author/Authors :
Barati, Behrooz Department of Otolaryngology - Head and Neck Surgery - School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran , Omrani, Mohammad Reza Department of Otolaryngology - Head and Neck Surgery - Sadi Hospital, Isfahan , Okhovat, Ahmad Reza Department of Otolaryngology - Head and Neck Surgery - School of Medicine - Isfahan University of Medical Sciences, Isfahan , Kelishadi, Roya Department of Pediatrics - Child Health Promotion Research Center - Isfahan University of Medical Sciences, Isfahan , Hashemi, Mustafa Department of Otolaryngology - Head and Neck Surgery - School of Medicine - Isfahan University of Medical Sciences, Isfahan , Hassanzadeh, Akbar Department of Epidemiology and Biostatistics - School of Health - Isfahan University of Medical Sciences, Isfahan , Abtahi, Mojtaba Department of otolaryngology - Head and Neck Surgery - School of Medicine - Isfahan University of Medical Sciences, Isfahan , Omidifar, Navid School of Medicine - Shiraz University of Medical Sciences, Shiraz , Okhovat, Hanif Department of Otorhinolaryngology - Head and Neck Surgery - School of Medicine - Isfahan University of Medical Sciences, Isfahan
Abstract :
BACKGROUND: Antimicrobials treatment of Otitis media (OM) reduces some complications, but some of chronic complications,
and specially otitis media with effusion (OME), seem to increase. Theoretically the usage of nasal corticosteroid
sprays may prevent this problem by reducing the local inflammation around the eustachian tube. So, this study
aimed to evaluate the role of nasal corticosteroid spray as an adjuvant for the treatment of OME.
METHODS: In a randomized, prospective clinical trial, 2 groups of 46 subjects who had OME were recruited. A questionnaire
containing patients' characters, history, complaints, otologic examinations and the report of tympanometries
was filled for all before and after treatment. We administered a period of amoxicillin and a decongestant for both group
and nasal beclomethasone spray only for case group.
RESULTS: Thirty five of cases (76.1%) and 22 (47.8%) of controls had an improvement in their symptoms or the quality
of hearing (p = 0.005). Partial remission was the most common finding in 52.2% of the patients in the case group but for
control group there was no change (p = 0.024). The higher improvement in the tympanic retraction in the case group
was significant (p < 0.05). A significant better tympanometric result has showed in the treatment of left ear in the patients
of the case group (p = 0.038) but not for right ear (p = 0.136).
CONCLUSIONS: We concluded that the administration of nasal beclomethasone spray as an adjuvant for the treatment of
OME not only improved the results treatment but also increased the resolution of symptoms and the patients' quality of
hearing.
Keywords :
Otitis Media with Effusion (OME) , Middle Ear Effusion (MEE) , Beclomethasone spray , Nasal Corticosteroids
